News
-
-
-
COMMUNIQUÉ DE PRESSE
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment avec leur Directeur Général, Daniel Tassé, pour discuter de leur technologie exclusive VIASKIN® pour les allergies alimentaires -
-
-
-
COMMUNIQUÉ DE PRESSE
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Press release on the total number of voting rights and shares of the Company as of July 31, 2025, in compliance with Article 223-16 of the AMF General Regulations -
-
-
COMMUNIQUÉ DE PRESSE
DBV Technologies announces filing of 2025 Half-Year Report ? Conditions for accessing or consulting the Report
DBV Technologies files 2025 Half-Year Report with market authority AMF, focusing on food allergy treatment options. Reports available on company & AMF websites, accessible by mail or email